These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2138253)

  • 1. Decreased production and responsiveness of interleukin 2 in lymphocytes of patients with nephrotic syndrome.
    Hinoshita F; Noma T; Tomura S; Shiigai T; Yata J
    Nephron; 1990; 54(2):122-6. PubMed ID: 2138253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of interleukin 2 (IL-2) and responsiveness to IL-2 of peripheral blood lymphocytes in minimal change nephrotic syndrome.
    Dohi K; Morita H; Ogawa S; Hirayama T; Yamada H; Ishikawa H
    Jpn J Med; 1991; 30(5):396-401. PubMed ID: 1803038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K; Ohi H; Kanmatsuse K
    Nephron; 1999; 82(1):32-8. PubMed ID: 10224482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum interleukin-7 level in idiopathic steroid-sensitive nephrotic syndrome.
    Kanai T; Shiraishi H; Yamagata T; Ito T; Odaka J; Saito T; Aoyagi J; Momoi MY
    Pediatr Int; 2011 Dec; 53(6):906-9. PubMed ID: 21486379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression of normal lymphocyte transformation by sera of patients with minimal change nephropathy and other forms of nephrotic syndrome.
    Taube D; Chapman S; Brown Z; Williams DG
    Clin Nephrol; 1981 Jun; 15(6):286-90. PubMed ID: 7249426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphocyte subpopulation, interleukin-2 and high affinity interleukin-2 receptor expression in primary nephrotic syndrome].
    Fu P; Xu G; Huang S; Yu T
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):83-5. PubMed ID: 12733363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy.
    Mandreoli M; Beltrandi E; Casadei-Maldini M; Mancini R; Zucchelli A; Zucchelli P
    Clin Nephrol; 1992 Apr; 37(4):177-82. PubMed ID: 1582055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lymphocyte blastogenesis by plasma of patients with minimal-change nephrotic syndrome.
    Moorthy AV; Zimmerman SW; Burkholder PM
    Lancet; 1976 May; 1(7970):1160-2. PubMed ID: 58203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte subpopulations in minimal-change nephropathy.
    Sasdelli M; Rovinetti C; Cagnoli L; Beltrandi E; Barboni F; Zucchelli P
    Nephron; 1980; 25(2):72-6. PubMed ID: 6965527
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracellular cytokines of peripheral blood lymphocytes in nephrotic syndrome.
    Zachwieja J; Bobkowski W; Dobrowolska-Zachwieja A; Lewandowska-Stachowiak M; Zaniew M; Maciejewski J
    Pediatr Nephrol; 2002 Sep; 17(9):733-40. PubMed ID: 12215827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome.
    Hulton SA; Shah V; Byrne MR; Morgan G; Barratt TM; Dillon MJ
    Pediatr Nephrol; 1994 Apr; 8(2):135-9. PubMed ID: 8018488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome.
    Kimata H; Fujimoto M; Furusho K
    Eur J Immunol; 1995 Jun; 25(6):1497-501. PubMed ID: 7614976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell mediated immunity in idiopathic glomerulonephritis.
    Sasdelli M; Cagnoli L; Candi P; Mandreoli M; Beltrandi E; Zucchelli P
    Clin Exp Immunol; 1981 Oct; 46(1):27-34. PubMed ID: 6978215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of T lymphocyte function and inhibitory factors in minimal change nephrotic syndrome.
    Tomizawa S; Suzuki S; Oguri M; Kuroume T
    Nephron; 1979; 24(4):179-82. PubMed ID: 315034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 production in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis.
    Oen K; Warrington R; Rosenberg AM; Krzekotowska D
    Clin Exp Immunol; 1988 Oct; 74(1):87-93. PubMed ID: 2975541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two-color analysis of lymphocyte subpopulations in membranous nephropathy and minimal change nephrotic syndrome].
    Ozaki T
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):797-806. PubMed ID: 2593316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble IL-2 receptor in patients with primary nephrotic syndrome.
    Ohno I; Gomi H; Matsuda H; Nakano H; Matsumoto H; Kodama K; Shibasaki T; Ishimoto F; Sakai O
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):483-9. PubMed ID: 1895547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased apoptosis of peripheral blood lymphocytes in children with nephrotic syndrome.
    Zachwieja J; Dworacki G; Bobkowski W; Dobrowolska-Zachwieja A; Zaniew M; Maciejewski J
    Pediatr Nephrol; 2002 Mar; 17(3):197-200. PubMed ID: 11956861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary excretion of interleukin-17 in nephrotic patients.
    Matsumoto K; Kanmatsuse K
    Nephron; 2002 Jun; 91(2):243-9. PubMed ID: 12053060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-18 is correlated with type-2 immune response in children with steroid sensitive nephrotic syndrome.
    Printza N; Papachristou F; Tzimouli V; Taparkou A; Kanakoudi-Tsakalidou F
    Cytokine; 2008 Nov; 44(2):262-8. PubMed ID: 18819819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.